Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Factors Affecting Dissolution: Particle Size and Effective Surface Area01:23

Factors Affecting Dissolution: Particle Size and Effective Surface Area

939
Dissolution kinetics, an essential aspect of oral drug delivery, is significantly influenced by the drug's particle size. According to the Noyes-Whitney dissolution model, the dissolution rate correlates directly with the drug's surface area. The larger the surface area, the higher the drug's solubility in water, leading to a faster drug dissolution rate. Reducing particle size increases the effective surface area, enhancing the dissolution process. Micronization and nanosizing are...
939
Drug Delivery: Miscellaneous Routes01:22

Drug Delivery: Miscellaneous Routes

436
Drug delivery methods like oral inhalation, nasal sprays, transdermal patches, eye drops, intravitreal injection,  and rectal administration provide localized effects with reduced toxicity.
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
436
Drug Delivery: Enteral Route01:18

Drug Delivery: Enteral Route

601
The enteral drug administration involves three primary routes: oral, sublingual, and buccal. Oral ingestion is the most prevalent, safe, economical, and convenient method for drug administration. However, it has certain drawbacks, including limited absorption due to the drug's low water solubility or poor membrane permeability, possible emesis from GI mucosa irritation, destruction of drugs by digestive enzymes or low gastric pH, and irregular absorption along with food or other drugs.
601
Routes of Drug Administration: Parenteral01:25

Routes of Drug Administration: Parenteral

2.1K
The administration of drugs via parenteral routes allows for direct drug introduction into the systemic circulation, resulting in high bioavailability because the medication bypasses the harsh conditions of the gastrointestinal tract and hepatic metabolism.
The intravenous route (IV) of drug administration can be further categorized into two types. The bolus injection administers the entire dose rapidly, while an intravenous infusion slowly delivers smaller doses steadily.
The IV route is often...
2.1K
Factors Influencing Drug Absorption: Pharmaceutical Parameters01:28

Factors Influencing Drug Absorption: Pharmaceutical Parameters

179
Solid dosage forms such as tablets and capsules undergo rigorous manufacturing processes to ensure stability and effectiveness. Their dissolution and absorption properties are influenced significantly by the choice of excipients (inactive ingredients that serve various roles in the formulation), and the methodology applied during production. The manufacturing parameters, such as compression force and granulation techniques, significantly affect dissolution rates. Elevated compression forces...
179
Drug Delivery: Parenteral Route01:29

Drug Delivery: Parenteral Route

732
The parenteral route is a critical method of drug administration. It delivers compounds directly into the systemic circulation and bypasses the gastrointestinal tract. This approach is particularly advantageous for drugs that exhibit poor absorption or instability when administered orally.
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
732

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Strategies to overcome hepatic clearance of endogenous proteins - molecular and formulation approaches.

RSC chemical biology·2026
Same author

From canes to pills: the evolution of carbon monoxide therapeutics.

Advanced drug delivery reviews·2026
Same author

Loss-of-function variants in the CAPN1 activator CD99L2 cause X-linked spastic ataxia.

Nature communications·2026
Same author

A Viral Neuraminidase-Specific Sensor for Taste-Based Detection of Influenza.

ACS central science·2025
Same author

Serum NfL, but not GFAP, differentiates primary lateral sclerosis from adrenomyeloneuropathy and hereditary spastic paraplegia type 4.

Amyotrophic lateral sclerosis & frontotemporal degeneration·2025
Same author

Spastic Ataxia Composite (SPAXCOM): A Scale to Evaluate the Progression of Subjects with Spasticity and Ataxia.

Movement disorders : official journal of the Movement Disorder Society·2025

Related Experiment Video

Updated: Aug 19, 2025

Disposable Dosators for Pulmonary Insufflation of Therapeutic Agents to Small Animals
04:22

Disposable Dosators for Pulmonary Insufflation of Therapeutic Agents to Small Animals

Published on: March 30, 2017

7.8K

Leveraging Dissolution by Autoinjector Designs.

Christoph Spangardt1,2, Christoph Keßler1, Ramona Dobrzewski1

  • 1Institute of Pharmacy and Food Chemistry, University of Wuerzburg, Am Hubland, 97074 Wuerzburg, Germany.

Pharmaceutics
|November 26, 2022
PubMed
Summary

Rapid autoinjectors deliver the organophosphate antidote HI-6 within ten seconds. This critical advancement ensures fast drug dissolution for life-saving treatment during chemical attacks.

Keywords:
autoinjectordissolutionnerve agentoximeresponse surface

More Related Videos

Author Spotlight: Developing a Disposable Dosator for Preclinical Testing of Dry Powder Inhalers in Small Animal Models
04:59

Author Spotlight: Developing a Disposable Dosator for Preclinical Testing of Dry Powder Inhalers in Small Animal Models

Published on: August 18, 2023

960
Rapid, Scalable Assembly and Loading of Bioactive Proteins and Immunostimulants into Diverse Synthetic Nanocarriers Via Flash Nanoprecipitation
06:57

Rapid, Scalable Assembly and Loading of Bioactive Proteins and Immunostimulants into Diverse Synthetic Nanocarriers Via Flash Nanoprecipitation

Published on: August 11, 2018

8.0K

Related Experiment Videos

Last Updated: Aug 19, 2025

Disposable Dosators for Pulmonary Insufflation of Therapeutic Agents to Small Animals
04:22

Disposable Dosators for Pulmonary Insufflation of Therapeutic Agents to Small Animals

Published on: March 30, 2017

7.8K
Author Spotlight: Developing a Disposable Dosator for Preclinical Testing of Dry Powder Inhalers in Small Animal Models
04:59

Author Spotlight: Developing a Disposable Dosator for Preclinical Testing of Dry Powder Inhalers in Small Animal Models

Published on: August 18, 2023

960
Rapid, Scalable Assembly and Loading of Bioactive Proteins and Immunostimulants into Diverse Synthetic Nanocarriers Via Flash Nanoprecipitation
06:57

Rapid, Scalable Assembly and Loading of Bioactive Proteins and Immunostimulants into Diverse Synthetic Nanocarriers Via Flash Nanoprecipitation

Published on: August 11, 2018

8.0K

Area of Science:

  • Chemical Engineering
  • Pharmacology
  • Emergency Medicine

Background:

  • Organophosphate exposure presents life-threatening emergencies requiring rapid medical intervention.
  • The oxime HI-6 is a crucial antidote but requires rapid dissolution due to its instability and the critical condition of exposed subjects.
  • Existing administration methods are challenged by patient incapacitation and the need for near-instantaneous drug availability.

Purpose of the Study:

  • To develop and validate autoinjector systems for rapid dissolution of the organophosphate antidote HI-6.
  • To meet stringent dissolution time requirements (under ten seconds) for emergency use.
  • To engineer reliable drug delivery devices for extreme conditions.

Main Methods:

  • Colorimetric profiling of dissolution dynamics using model dyes in various autoinjector designs.
  • Integration of online conductometry for precise measurement with the active molecule HI-6.
  • Development of small-scale rotor systems to enhance dissolution efficiency across different viscosities.

Main Results:

  • Successfully profiled HI-6 dissolution within prototype autoinjectors.
  • Demonstrated that integrated rotor systems significantly improve dissolution rates.
  • Achieved dissolution specifications critical for immediate administration in emergency scenarios.

Conclusions:

  • The developed autoinjector designs with rotor systems reliably meet the ten-second dissolution requirement for HI-6.
  • These advancements are crucial for effective emergency treatment of organophosphate exposure.
  • The study provides blueprints for autoinjectors optimized for rapid drug delivery in high-stress situations.